Contribution of soluble endotoxin released from Gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice

Journal of Endotoxin Research

Volumn 3, Issue 3, 1996, Pages 237-243

  Morrison, D C ^a   Bucklin, S E ^a   Leeson, M C ^a   Norimatsu, M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CEFTAZIDIME; DEXTRAN; ENDOTOXIN; ENDOTOXIN ANTIBODY; GALACTOSAMINE; IMIPENEM; MONOCLONAL ANTIBODY; POLYMYXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; PROTECTION; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0029768726     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300309     Document Type: Conference Paper

References (19)

1. Morrison D.C., Danner R.L., Dinarello C.A. et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J Endotoxin Res 1994; 1: 71-83.
2. Centers for Disease Control, National Center for Health Statistics, 1992.
3. Bone R.C., Balk R.A., Cerra F.B. et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655.
4. Kreger B.E., Craven D.E., McCabe W.R. Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344-355.
5. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. In: Creger WP, ed. Annual Reviews in Medicine, Palo Alto, CA, USA: Ann Reviews Inc., 1987; pp 417-432.
6. Cross A.S., Opal S. Therapeutic intervention in sepsis with antibody to endotoxin: is there a future? J Endotoxin Res 1994; 1: 57-69.
7. Spink W.W., Hall W.H., Shaffer J.M., Braude A.I. Human brucellosis: its specific treatment with a combination of streptomycin and sulfadiazine. JAMA 1948; 136: 382.
8. Hurley J.C. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840-854.
9. Leeson M.C., Morrison D.C. Induction of proinflammatory responses in human monocytes by particulate and soluble forms of lipopolysaccharide. Shock 1994; 2: 235-245.
10. Leeson M., Fujihara Y., Morrison D.C. Evidence for lipopolysaccharide (LPS) as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect Immun 1994; 62: 4975-4980.
11. Galanos C., Freudenberg M.A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1970; 76: 5939-5943.
12. Galanos C., Freudenberg M., Katschinski T., Salomao R., Mossman H., Kumazawa Y. Tumor necrosis factor and host response to endotoxin. In: Ryan J.L., Morrison D.C. eds. Bacterial Endotoxic Lipopolysaccharides, Volume II Immunopharmacology and Pathophysiology. Boca Raton, FL: CRC Press, 1992; 75-104.
13. Bucklin S.E., Morrison D.C. Differences in therapeutic efficacy among cell wall active antibiotics in a mouse model of Gramnegative sepsis. J Infect Dis 1995; 172: 1519-1527.
14. Bucklin S.E., Lake P., Logdberg L., Morrison D.C. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrob Agents Chemother 1995; 39: 1462-1466.
15. Jackson J.J., Kropp H. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
16. Jackson J.J., Kropp H. Endotoxin liberation: influence on in vivo beta-lactam antibiotic efficacy. In: Morrison D.C. ed. Gram-Negative Infections and Sepsis: From Basic Concepts to Clinical Chemotherapy. Whitehouse Station, NJ, USA: Merck 1995; 11-17.
17. Prins J.M., van Agtmael M.A., Kuijper E.J., van Deventer S.J.H., Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
18. Derkx H.H.F., Bruin K.F., Jongeneel C.V. et al. Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro; relationship to TNF gene polymorphism. J Endotoxin Res 1995; 2: 19-25.
19. Prins J.M., Kuijper E.J., Mevissen M.L. et al. Release of TNF and IL-6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration and presence of septic serum. Infect Immun 1995; 63: 2236-2242.